Breast cancer

FILE - In this Jan. 23, 2019, file photo, Syracuse's Tiana Mangakahia dribbles down court in the second quarter of an NCAA basketball game against Miami in Syracuse, N.Y. Mangakahia is halfway through treatment for breast cancer and says she often wonders “Why me?” One of the top women’s basketball players in the country and a player who nearly elected to enter the WNBA draft, the star from Australia says the feedback from doctors has been good and she’ll receive more tests Friday updating the status of her recovery. (AP Photo/Nick Lisi, File)
August 20, 2019 - 5:33 pm
SYRACUSE, N.Y. (AP) — The question "Why me?" has entered her mind, but Tiana Mangakahia knows these things happen all the time. The 24-year-old star point guard for the Syracuse women's basketball team was diagnosed with breast cancer about two months ago, and now she is halfway through...
Read More
FILE - This undated fluorescence-colored microscope image made available by the National Institutes of Health in September 2016 shows a culture of human breast cancer cells. On Tuesday, Aug. 20, 2019, the U.S. Preventive Services Task Force recommended more women should consider gene testing for hereditary breast or ovarian cancer, especially those who've already survived cancer once. (Ewa Krawczyk/National Cancer Institute via AP)
August 20, 2019 - 11:09 am
WASHINGTON (AP) — New health guidelines say more women may benefit from gene testing for hereditary breast or ovarian cancer, especially if they already survived cancer once. Mutations in genes called BRCA1 (pronounced B-R-C-A) and BRCA2 aren't common, but when they're passed through families they...
Read More
June 03, 2019 - 5:12 pm
CHICAGO (AP) — Newer drugs are substantially improving the chances of survival for some people with hard-to-treat forms of lung, breast and prostate cancer, doctors reported at the world's largest cancer conference. Among those who have benefited is Roszell Mack Jr., who at age 87 is still able to...
Read More
FILE - In this Sept. 18, 2014 file photo, produce is displayed for sale at a farmers market in Kalamazoo, Mich. A study released on Wednesday, May 15, 2019 suggests that trimming dietary fat and eating more fruits and vegetables may lower a woman's risk of dying of breast cancer. (Katie Alaimo/Kalamazoo Gazette via AP)
May 15, 2019 - 5:06 pm
For the first time, a large experiment suggests that trimming dietary fat and eating more fruits and vegetables may lower a woman's risk of dying of breast cancer. The results are notable because they come from a rigorous test involving 49,000 women over two decades rather than other studies that...
Read More
FILE - This Dec. 11, 2006 file photo shows a silicone gel breast implant in Irving, Texas. U.S. health officials are taking another look at the safety of breast implants, the latest review in a decades-long debate. At a two-day meeting that starts Monday, March 25, 2019, a panel of experts for the U.S. Food and Drug Administration will hear from researchers, plastic surgeons and implant makers, as well as from women who believe their ailments were caused by the implants. (AP Photo/Donna McWilliam, File)
March 25, 2019 - 9:30 pm
SILVER SPRING, Md. (AP) — Government medical advisers said Monday it's too soon to ban a type of breast implant that has recently been linked to a rare form of cancer, saying more information is needed to understand the problem. The Food and Drug Administration panel didn't recommend any immediate...
Read More
FILE - This Oct. 14, 2015 file photo shows the Food & Drug Administration campus in Silver Spring, Md. On Friday, March 8, 2019, the FDA approved Roche’s Tecentriq, the first cancer immunotherapy for treating an aggressive type of breast cancer. (AP Photo/Andrew Harnik, File)
March 08, 2019 - 6:26 pm
The U.S. Food and Drug Administration has approved the first immunotherapy drug for breast cancer. Swiss drugmaker Roche's Tecentriq was OK'd Friday for treating advanced triple-negative breast cancer, which accounts for about 15 percent of cases. It's to be given with chemotherapy, the standard...
Read More